These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7687292)

  • 1. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
    Kanayama T; Kimura Y; Mizogami S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):344-9. PubMed ID: 7687292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of a new prostacyclin analogue, KP-10614, on acute myocardial infarction in rats.
    Kanayama T; Kimura Y; Tamao Y; Mizogami S
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):630-7. PubMed ID: 1280720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration.
    Rampart M; Williams TJ
    Am J Pathol; 1986 Jul; 124(1):66-73. PubMed ID: 3524253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin.
    Maugeri N; de Gaetano G; Barbanti M; Donati MB; Cerletti C
    Haematologica; 2005 Jun; 90(6):833-9. PubMed ID: 15951297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis.
    Maugeri N; Evangelista V; Celardo A; Dell'Elba G; Martelli N; Piccardoni P; de Gaetano G; Cerletti C
    Thromb Haemost; 1994 Sep; 72(3):450-6. PubMed ID: 7531878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
    Hsu MF; Chang LC; Huang LJ; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2009 Apr; 607(1-3):234-43. PubMed ID: 19232341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcellular metabolism of arachidonic acid in platelets and polymorphonuclear leukocytes activated by physiological agonists: enhancement of leukotriene B4 synthesis.
    Palmantier R; Borgeat P
    Adv Exp Med Biol; 1991; 314():73-89. PubMed ID: 1667970
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction.
    Evers AS; Murphree S; Saffitz JE; Jakschik BA; Needleman P
    J Clin Invest; 1985 Mar; 75(3):992-9. PubMed ID: 3980734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide is not involved in hepatocyte killing by neutrophils activated by N-formyl-methionyl-leucylphenylalanine or phorbol myristate acetate in vitro.
    Wagner JG; Ganey PE; Roth RA
    Hepatology; 1996 Apr; 23(4):803-10. PubMed ID: 8666335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PGI2 analog iloprost on myocardial infarct size, regional myocardial blood flow, and platelet function in rabbits with coronary artery occlusion followed by reperfusion.
    Golino P; Cappelli-Bigazzi M; Perrone-Filardi P; Nevola E; Quattrin S; Salvatore M; Chiariello M
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():377-80. PubMed ID: 2444078
    [No Abstract]   [Full Text] [Related]  

  • 15. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood.
    Izzi B; Pampuch A; Costanzo S; Vohnout B; Iacoviello L; Cerletti C; de Gaetano G
    Thromb Haemost; 2007 Dec; 98(6):1276-84. PubMed ID: 18064325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
    Darius H; Michael-Hepp J; Thierauch KH; Fisch A
    Eur J Pharmacol; 1994 Jun; 258(3):207-13. PubMed ID: 7522176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.
    Evangelista V; Piccardoni P; de Gaetano G; Cerletti C
    Thromb Haemost; 1992 Jun; 67(6):660-4. PubMed ID: 1509406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms.
    Colli S; Tremoli E
    J Lab Clin Med; 1991 Aug; 118(2):136-45. PubMed ID: 1649884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 7-oxo-PGI2 on myocardial infarct size and role of oxygen radicals in its protective effect.
    Ranaut K; Singh M; Chopra K; Ganguly NK
    Arch Int Pharmacodyn Ther; 1993; 324():75-86. PubMed ID: 8297188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury.
    Squadrito F; Altavilla D; Squadrito G; Saitta A; Deodato B; Arlotta M; Minutoli L; Quartarone C; Ferlito M; Caputi AP
    J Mol Cell Cardiol; 2000 Mar; 32(3):429-40. PubMed ID: 10731442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.